Vyvanse — Class III drug recall D-0006-2017
Terminated recall by Shire, reported 2016-10-12, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0006-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Shire, Chesterbrook, PA, United States |
| Recall initiated | 2016-09-02 |
| Classified | 2016-10-05 |
| Reported by FDA | 2016-10-12 |
| Terminated | 2019-03-08 |
| Distributed | Nationwide (US) |
| NDC | 59417-0101, 59417-0101-10, 59417-0102, 59417-0102-10, 59417-0103, 59417-0103-10, 59417-0104, 59417-0104-10, 59417-0105, 59417-0105-10, 59417-0106, 59417-0106-10, 59417-0107, 59417-0107-10, 59417-0115, 59417-0115-01, 59417-0116, 59417-0116-01, 59417-0117, 59417-0117-01, 59417-0118, 59417-0118-01, 59417-0119, 59417-0119-01, 59417-0120 and 1 more |
| Lot numbers | 04/19, AF3360B |
Product
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0006-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.